MH
Senior Reporter, GLP-1
Maren Holt
Covers the incretin market, compounded GLP-1 supply and the telehealth companies selling it.
Beats: GLP-1, Compounding · 60 entries on the wire
HSS Studies Flag Preoperative Gastric Assessment Challenges Amid Rising GLP-1 Use
By Maren HoltPEPTI prices every GLP-1 dose step separately, breaking flat-fee norm
By Maren HoltHanover Foods aims Skinny Veg line at GLP-1 consumers
By Maren HoltReview examines de-escalating sleep apnoea therapy after GLP-1 weight loss
By Maren HoltAmazon Expands GLP-1 Management Program to 48 States and Washington, DC
By Maren HoltCase report links tirzepatide use to duodenal ulcer perforation
By Maren HoltStudy finds GLP-1 pills curb snacking less than injections
By Maren HoltCleveland Clinic Examines Whether GLP-1 Patches Deliver Results
By Maren HoltNew Weight-Loss Pills Curb Snacking Less Than GLP-1 Injections
By Maren HoltExperts Urge Eating-Disorder Screening Before Starting GLP-1 Therapy
By Maren HoltTelehealth provider GobyMeds faces scrutiny over dose-based GLP-1 pricing
By Maren HoltReport Breaks Down Cash-Pay GLP-1 Costs at Form Health
By Maren HoltFifty410 GLP-1 pricing reviewed for dose-escalation increases
By Maren HoltBelle alternatives compared as GLP-1 telehealth price competition intensifies
By Maren HoltEmerge Weight Loss GLP-1 pricing examined across dose increases
By Maren HoltReport suggests GLP-1 drugs could help older adults with frailty
By Maren HoltGLP-1 use tied to 11-fold higher regurgitation rate under anesthesia
By Maren HoltLocal broadcast segment reviews GLP-1 side effects and muscle loss
By Maren HoltWillow markets online GLP-1 weight-management program in 2026 review
By Maren HoltMEDVi swaps PT-141 for apomorphine in compounded ED formula
By Maren HoltConsumer guide compares cheaper GLP-1 telehealth providers against 10Rx
By Maren HoltSesame Care Tirzepatide Pricing Remains Unverified, Report Says
By Maren HoltWPRI profiles woman's experience in GLP-1 weight-loss program
By Maren HoltCBS News examines common misconceptions about Ozempic, Wegovy, Zepbound
By Maren HoltExperts Flag Fasting Considerations for GLP-1 Users on Yom Kippur
By Maren HoltClinicians Examine GI Risk From GLP-1 and Opioid Combination
By Maren HoltClinicians Report Rare Neurologic Complication With GLP-1 Weight Loss
By Maren HoltWABI Segment Outlines What Patients Should Know Before Starting GLP-1s
By Maren HoltElvinix licenses Zealand Pharma GLP-1/gastrin portfolio for type 1 diabetes
By Maren HoltPEPTI undercuts every ranked GLP-1 program: semaglutide $119, tirzepatide $139, no membership
By Maren Holt
Local report outlines considerations before starting GLP-1 weight-loss drugs
By Maren HoltAscendis regains obesity rights as Novo Nordisk exits monthly GLP-1 deal
By Maren HoltApplied Clinical Trials brief examines cortisol influence on GLP-1 response
By Maren HoltMedscape weighs GLP-1 therapy limits in obstructive sleep apnea
By Maren HoltPhysician's Weekly assesses GLP-1 pricing and coverage shifts for clinicians
By Maren HoltNovo halts once-monthly obesity drug as part of strategic reset
By Maren HoltSONAR Report Links GLP-1 Receptor Agonists to Severe Thrombocytopenia
By Maren HoltNovo Nordisk Exits Another Monthly GLP-1 Programme
By Maren HoltMedscape Asks Whether Statins Still Matter in GLP-1 Era
By Maren HoltPlexusDx Reviews OrderlyMeds GLP-1 Dose Pricing Claims
By Maren HoltExplainer Outlines Eli Lilly Triple-Agonist Retatrutide for Weight Loss
By Maren HoltAllure Examines How GLP-1s Moved Beyond the Doctor's Office
By Maren HoltZealand Pharma licenses GLP-1/gastrin peptide platform to Elvinix
By Maren HoltPEPTI prices its BPC-157 and TB-500 recovery protocol at $259 a month
By Maren HoltReview assesses oral GLP-1 impact on UK obesity policy
By Maren HoltNovo exits $285M Ascendis deal for monthly GLP-1 obesity drug
By Maren HoltAscendis reclaims Novo Nordisk rights in diabetes and obesity push
By Maren HoltComparison Ranks Gimme Alternatives for GLP-1 Treatment in 2026
By Maren HoltGuide Compares Rex MD Alternatives for GLP-1 Weight Loss
By Maren HoltAlan Meds Keeps Tirzepatide Pricing Undisclosed, Review Finds
By Maren HoltForbes ranks six cheapest online tirzepatide providers for 2026
By Maren HoltCurifyLabs targets US compounding pharmacy growth at industry events
By Maren HoltArbor markets GLP-1 plans starting at $99 per month
By Maren HoltTirzepatide reshaped sleep apnea care, clinicians eye more peptides
By Maren HoltLavender Sky Health tirzepatide pricing detailed across plans and doses
By Maren HoltPlexusDx compares annual prepay versus monthly GLP-1 telehealth plans
By Maren HoltPlexusDx breaks down Rex MD monthly pricing for Wegovy programs
By Maren HoltPlexusDx ranks Levity alternatives for GLP-1 treatment in 2026
By Maren HoltPlexusDx compares AltRx alternatives and pricing for GLP-1 care
By Maren HoltPlexusDx lists cheaper GLP-1 providers than OrderlyMeds
By Maren Holt